Ilaprazole sodium hydrate

• CAT Number: I040437
• CAS Number: 2322264-11-7
• Molecular Formula: C19H21N4NaO4S
• Molecular Weight: 424.45
• Purity: ≥95%
• Synonyms: sodium;2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-5-pyrrol-1-ylbenzimidazol-1-ide
• InChI: InChI=1S/C19H17N4O2S.Na/c1-13-17(20-8-7-18(13)25-2)12-26(24)19-21-15-6-5-14(11-16(15)22-19)23-9-3-4-10-23;/h3-11H,12H2,1-2H3;/q-1;+1
• InChIKey: ZQGDDMFDBZPGCD-UHFFFAOYSA-N
• SMILES: CC1=C(C=CN=C1CS(=O)C2=NC3=C([N-]2)C=CC(=C3)N4C=CC=C4)OC.[Na+]

Ilaprazole sodium hydrate(CAT: I040437)  is an orally active, irreversible proton pump inhibitor (PPI) that suppresses gastric acid secretion by targeting H⁺/K⁺-ATPase in a dose-dependent manner (IC₅₀ = 6 μM in rabbit parietal cells). It exhibits potent acid-inhibitory effects in vivo, significantly raising gastric pH in histamine-stimulated rats and demonstrating superior potency to omeprazole in intraduodenal models (ED₅₀ = 0.43 mg/kg vs. 0.68 mg/kg). Additionally, Ilaprazole sodium hydrate acts as a potent TOPK kinase inhibitor, expanding its relevance to cancer and inflammation research. With strong efficacy in reducing both basal and stimulated acid secretion, it is a valuable tool in gastric ulcer and gastroenterological studies.